recent press releases

Dermelix Biotherapeutics Announces Partnership with EspeRare for Pivotal-stage Antenatal Protein Replacement Therapy for XLHED
April 2, 2019

The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Dermelix disavows any obligation to update the information contained in such press releases after the date of their issuance.